Four Inc. Collaborates with Genesys to Deliver Enhanced Customer Experience Solutions to the Public Sector
Four Inc. will leverage its deep understanding of the public sector market to bring the Genesys Cloud platform to a wider audience. This will empower agencies to modernize their communication infrastructure, streamline operations, and provide seamless, personalized experiences to citizens across all channels.
"Four Inc. is committed to providing our public sector customers with innovative and effective IT solutions," said Chris Wilkinson, EVP of Sales at Four Inc. "Partnering with Genesys strengthens our ability to offer our partners and customers access to cutting-edge cloud-based experience orchestration solutions. This will improve citizen engagement through seamless and personalized experiences for constituents across various communication channels."
With Genesys Cloud, organizations can coordinate every interaction and touchpoint through a full suite of omnichannel options, built-in employee experience, native and turnkey AI and end-to-end journey optimization.
Genesys Cloud will be available via Four Inc.'s NASA SEWPV, ITES-SW2, GSA, OMNIA Contract Vehicles. For more information, contact Four Inc. at sales@fourinc.com.
About Four Inc.Four Inc. is a trusted Public Sector IT Distributor and has been recognized as a Top 100 government contractor on Washington Technology's Top 100 Report consecutively for the last ten years. Four Inc.'s expertise of the federal IT contracting process and their carefully crafted ecosystem of manufacturers and partners has enabled them to expertly deliver the right technology solutions and services to their customers. Through their proven experience and dedication to their core values, they have earned the IT community's respect and trust.
Media Contactmarketing@fourinc.com
View original content:https://www.prnewswire.com/news-releases/four-inc-collaborates-with-genesys-to-deliver-enhanced-customer-experience-solutions-to-the-public-sector-302481921.html
SOURCE Four LLC
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
28 minutes ago
- Business Wire
Fresh Del Monte Produce Inc. Clarifies It Is Not Affiliated with Del Monte Foods Inc.
CORAL GABLES, Fla.--(BUSINESS WIRE)-- Fresh Del Monte Produce Inc. (NYSE: FDP) is a fully independent, publicly traded company with no financial or operational affiliation with Del Monte Foods Inc., a separate entity currently involved in litigation and bankruptcy proceedings. The two companies are entirely separate entities, with no shared ownership, governance, or operations. Del Monte Foods Inc. is a privately held U.S. company owned by a parent organization based in Singapore. Fresh Del Monte Produce Inc.'s financial or operational performance is not impacted by that separate, unaffiliated company's announced legal or financial proceedings. While both businesses share rights to the Del Monte® name through historical licensing arrangements, they operate under distinct ownership and serve different geographic markets. Fresh Del Monte continues to operate with full stability and focus. The company remains financially strong, strategically aligned, and committed to delivering long-term value. It will report second quarter 2025 results during its scheduled earnings call on Wednesday, July 30, 2025. Fresh Del Monte is a global leader in fresh and fresh-cut produce: Headquartered in Coral Gables, FL, with operations in over 90 countries. The global leader in pineapple innovation. Owner of the Del Monte® brand for prepared food products in Europe, Africa, and the Middle East. Del Monte Foods Inc. — a different company with no affiliation to Fresh Del Monte — holds the rights to the Del Monte® brand for prepared food products in the U.S. It does not have rights to fresh or fresh-cut fruit. Customers, suppliers, and partners can remain confident in the continuity of Fresh Del Monte's operations and its commitment to delivering high-quality, Del Monte®-branded products, services, and trusted support. For more information about the company's global operations and financial performance, please visit the Investor Relations page. Fresh Del Monte Produce Inc. is one of the world's leading vertically integrated producers, marketers, and distributors of high-quality fresh and fresh-cut fruit and vegetables, as well as a leading producer and distributor of prepared food in Europe, Africa, and the Middle East. Fresh Del Monte Produce Inc. markets its products worldwide under the DEL MONTE ® brand (under license from Del Monte Foods, Inc.), a symbol of product innovation, quality, freshness, and reliability for over 135 years. The company also markets its products under the MANN ® brand and other related trademarks. Fresh Del Monte Produce Inc. is not affiliated with certain other Del Monte companies around the world, including Del Monte Foods, Inc., the U.S. subsidiary of Del Monte Pacific Limited, Del Monte Canada, or Del Monte Asia Pte. Ltd. Fresh Del Monte Produce Inc. is the first global marketer of fruits and vegetables to commit to the 'Science Based Targets' initiative. In 2022, 2023, and 2024, Fresh Del Monte Produce was ranked as one of 'America's Most Trusted Companies' by Newsweek based on an independent survey rating companies on three different touchpoints, including customer trust, investor trust, and employee trust. The company was also named a Humankind 100 Company for two consecutive years by Humankind Investments, which recognizes companies that substantially impact areas such as access to food and clean water, healthcare, and digital services. Fresh Del Monte has also been awarded the SEAL Business Sustainability Awards four times in the last five years (2021, 2023, 2024, and 2025). Fresh Del Monte Produce Inc. is traded on the NYSE under the symbol FDP.
Yahoo
28 minutes ago
- Yahoo
Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and infants who were born during or entering their first RSV season. To provide a brief context, ENFLONSIA happens to be a preventive, long-acting monoclonal antibody (mAb) which has been designed to offer direct, rapid, and durable protection through 5 months, a typical RSV season, with the same 105 mg dose irrespective of weight. Merck & Co., Inc. (NYSE:MRK) further mentioned that the typical RSV season generally spans autumn to spring of the next year. A close-up of a person's hand holding a bottle of pharmaceuticals. However, ENFLONSIA should not be administered to infants who have a history of serious hypersensitivity reactions, including anaphylaxis, to any of the components of ENFLONSIA. Merck & Co., Inc. (NYSE:MRK) added that the approval is basis the results from the pivotal Phase 2b/3 CLEVER trial (MK-1654-004) evaluating a single dose of ENFLONSIA administered to preterm and full-term infants. Furthermore, the focus is to ensure the availability of ENFLONSIA in the US before the upcoming RSV season begins. This is to help in reducing the significant burden of the widespread seasonal infection on families and health care systems. Artisan Partners, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Shares of Merck & Co., Inc. (NYSE:MRK), a health care solutions company, were down 9%. Operating results have been solid, with Q4 earnings beating expectations, but investors were more focused on the continued weak demand in China for Gardasil, a vaccine for human papillomavirus (HPV), and the company's decision to pause vaccine shipments through at least mid-2025 to pare inventories. Though recent Gardasil setbacks have weighed on sentiment, the overarching issue for shareholders remains the success of Merck's late-stage pipeline to replace sales that will be lost when blockbuster oncology drug Keytruda (50% of Q4sales) comes off patent in 2028. As shares sell cheaply at just 10X earnings, Merck seems to be getting little credit from investors for the 60+ programs it has in clinical development, despite having several solid and large new product opportunities. Additionally, the company's strong balance sheet and robust free cash flow provide it multiple options for future partnerships and acquisitions, besides return of capital to shareholders via dividends and share repurchases.' While we acknowledge the potential of MRK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds' investor letters by entering your email address below. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
Unum Group to Release Second Quarter 2025 Results and Host Conference Call
CHATTANOOGA, Tenn., July 03, 2025--(BUSINESS WIRE)--Unum Group (NYSE: UNM) will release its second quarter 2025 results on July 29, 2025, at approximately 4:15 p.m. ET. The earnings release and financial supplement will be available in the investors section of the company's website, which can be directly accessed at Members of Unum Group's senior management will host a conference call on July 30, 2025, at 8:00 a.m. ET to discuss second quarter operations results. Topics may include forward-looking information, such as guidance on future results or trends in operations, as well as other material information. Interested parties are invited to listen and participate in the question-and-answer segment. To receive dial-in information for the call, please register in advance through the URL below. Dial In Registration URL: A live webcast of the call will be available in a listen-only mode. Participants should access the webcast approximately 10 minutes before the call. Webcast URL: Unum will keep a recording of the call on the Investor site through August 6, 2025. The replay can be accessed through the same dial-in registration URL above. Anticipated future earnings release dates / conference call dates & times: Third Quarter 2025 – November 4th / November 5th 8 Quarter 2025 – February 3rd / February 4th 8 Quarter 2026 – April 28th / April 29th 8 a.m. About Unum Group Unum Group (NYSE: UNM), a leading international provider of workplace benefits and services, has been helping workers and their families thrive for more than 175 years. Through its Unum and Colonial Life brands, the company offers disability, life, accident, critical illness, dental, and vision insurance; leave and absence management support; and behavioral health services. In 2024, Unum Group reported revenues of $12.9 billion and paid $8.0 billion in benefits. The Fortune 500 company is recognized as one of the World's Most Ethical Companies by Ethisphere®. Visit the Unum Group newsroom for more information, and connect with us on LinkedIn, Facebook and Instagram. View source version on Contacts MEDIADottie McCallendmccallen@ INVESTORSMatt Royalinvestorrelations@ Sign in to access your portfolio
